return to small text site

 

for patients

press releases

press coverage
electronic press kit
Luveniq

LX214

LX212
proprietary technologies
pipeline

uveitis

dry eye syndrome

age-related macular degeneration

history
management
board of directors

investors

About

Ophthalmic Indications
Products &
Technologies

Partners

News & Media
Careers
Contact Us

 

  Press Coverage
 

September 30, 2009 -- Ophthalmology Times
Potential best in class for dry eye

July/August 2008  -- Drug Delivery Technology
Ocular Delivery:  New Controlled Release Technologies Broaden Opportunities for Ophthalmic Therapies

June 15, 2007  --  Ocular Surgery News U.S. Edition
Implant could reduce risk of corneal graft rejection

February 21, 2007 --  BioWorld Today
Lux Starts Phase III Studies; Isotechnika Raises $34.5M

January 2007 --  Start-Up
Windhover's Review of Emerging Medical Ventures

The A-List: 2006's Trend-Shaping Series A Financings


© 2009 Lux Biosciences, Inc. All rights reserved.           Web Terms           Clinical Trials